Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova (V.SVA) puts focus on diabetes treatment device

Stockhouse Editorial
0 Comments| May 16, 2014
{{labelSign}}  Favorites
{{errorMessage}}
Top Bullboards post:

“Raymond James raised their target price on shares of Air Canada from$6 to $6.50 in a research note on Friday,’’ wrote trojanhero in an Air Canada (TSX: T.AC.B, Stock Forum) post.

Top Bullboard:

Adira Energy Ltd. (TSX: V.ADL, Stock Forum) was the most popular bullboard.

Top blog:

Blogger nopoo highlights a Sernova Corp. (TSX: V.SVA, Stock Forum) company overview.

{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today